image
Eledon Pharmaceuticals, Inc. ELDN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.0
-3.15 %
$ 239 M
Market Cap
8.89
P/E
BALANCE SHEET
89.1 M ASSETS
-4.02%
Growth Rates
1Year -4.02%
3Years -23.27%
5Years 39.23%
7Years 16.95%
10Years 10.68%
81.9 M LIABILITIES
850.73%
Growth Rates
1Year 850.73%
3Years 131.60%
5Years 100.38%
7Years 61.13%
10Years -0.67%
7.21 M EQUITY
-91.44%
Growth Rates
1Year -91.44%
3Years -66.43%
5Years -13.04%
7Years -17.13%
10Years 7.86%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Eledon Pharmaceuticals, Inc.
image
Current Assets 56.1 M
Cash & Short-Term Investments 51.1 M
Receivables 0
Other Current Assets 5.03 M
Non-Current Assets 32.9 M
Long-Term Investments 0
PP&E 365 K
Other Non-Current Assets 32.6 M
Current Liabilities 3.9 M
Accounts Payable 967 K
Short-Term Debt 766 K
Other Current Liabilities 2.16 M
Non-Current Liabilities 78 M
Long-Term Debt 0
Other Non-Current Liabilities 78 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 4.6 56.4 84.8 114.2 8.8 13.0 17.2 23.2 24.0 105.3 31.8 11.7
Short Term Investments 46.5 0 0 0 0 0 0 4.2 39.9 0 0 0
Receivables 0 0 0 0.1 0.2 0 0 0 0 0 0 0
Inventory 0 0 0 1.3 0.9 0 0 0 0 0 0 0
Other Current Assets 5.0 3.1 3.5 1.3 0.9 1.3 1.8 47 K 3.3 2.3 0.4 0.2
Total Current Assets 56.1 59.5 88.3 115.6 10.0 14.3 19.0 29.5 67.2 107.5 32.2 11.9
PP&E 0.4 0.7 0.8 0.1 0.3 14 K 25 K 98 K 0.5 33 K 29 K 16 K
Intangible Assets 32.4 32.4 32.4 32.4 0 0 0 0 0 0 0 0
Goodwill 0 0 48.6 48.6 0 1.9 1.9 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0.3 0 0 0
Other Long Term Assets 0.2 0.1 0.4 0.4 0.6 0.9 0 0.1 45 K 0.2 80 K 20 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 89.1 92.8 170.5 197.2 10.9 17.0 20.9 29.8 68.0 107.7 32.3 12.0
LIABILITIES
Accounts Payable 1.0 2.2 1.8 1.4 0.3 0.7 0.4 0.3 1.2 0.8 5 K 0.8
Short Term Debt 0.8 0.7 0.7 0.3 0.2 0 0 3.4 0 0 0 0
Other Current Liabilities 2.2 3.5 1.9 0.8 0.8 1.8 1.0 0.1 5.0 3.5 2.2 1.3
Total Current Liabilities 3.9 6.5 4.4 2.5 1.3 2.5 1.4 2.8 6.2 4.2 2.2 2.0
Long Term Debt 0 0.4 0.4 0 0.1 0 0 0 0 0 0 0
Deferred Tax Income 1.8 1.8 1.8 4.1 0 0 0 0 0 0 0 0
Other Liabilities 76.2 0 0 0 0 0 0 0 88 K 0 85.3 49.8
Total Liabilities 81.9 8.6 6.6 6.6 1.5 2.5 1.4 2.9 6.2 4.2 87.6 51.9
EQUITY
Common Stock 24 K 14 K 14 K 15 K 13 K 9 K 7 K 23 K 23 K 22 K 0 0
Retained Earnings (319.4) (202.9) (114.9) (80.4) (57.6) (41.6) (27.5) (169.4) (131.4) (86.4) (63.1) (47.3)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 1 K 55 K 58 K 43 K 51 K
Total Equity 7.2 84.2 164.0 190.6 9.5 14.5 19.5 26.9 61.7 103.5 (55.3) (39.9)
Total Liabilities and Equity 89.1 92.8 170.5 197.2 10.9 17.0 20.9 29.8 68.0 107.7 32.3 12.0
SHARES OUTSTANDING
Common Shares Outstanding 24 619.2 14.3 14.8 1.5 0.7 0.5 0.3 21.3 K 0.1 39.9 K 94.8 K 94.8 K